Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation.
In humans, insert mutations within the repetitive octapeptide region of the prion protein gene (Prnp) are often associated with familial spongiform encephalopathies. In this study, transgenic mice expressing bovine PrP (boTg mice) bearing an additional octapeptide insertion to the wild type (seven octapeptide repeats instead of six) showed an altered course of bovine spongiform encephalopathy (BSE) infection, reflected as reduced incubation times when compared with boTg mice expressing similar levels of the wild-type six-octapeptide protein. In both boTg mouse lines (bo6ORTg and bo7ORTg), incubation times were affected drastically depending on transgene expression levels and the inoculum used. In accordance with the lack of an interspecies barrier to BSE infection, we detected the typical signs of CNS spongiform degeneration by histopathological analysis and the presence of the bovine prion PrP(res) by Western blot or immunohistochemical analyses. When 7OR-PrP(res) was propagated in bo7ORTg mice, a similar earlier onset of clinical signs was observed compared with bo6ORTg mice. Proteins PrP(C) and PrP(res) containing seven octapeptides (7OR-PrP(C) and 7OR-PrP(res)) showed similar protease sensitivity and insolubility in nondenaturing detergents to homologous 6OR-PrP(C) and 6OR-PrP(res). In addition, bo7ORTg mice showed a higher sensitivity than bo6ORTg mice for detecting prion infection in specimens previously diagnosed as negative by conventional biochemical techniques. In the absence of clinical signs of disease, 7OR-PrP(res) could be detected as early as 120 d after inoculation by immunohistochemical and Western blot analyses. These findings may help us improve the current mouse bioassays and understand the role of the octapeptide repeat region in susceptibility to disease.
Castilla
J
J
Center of Animal Health Investigation, National Institute of Agricultural Technology and Investigation, Valdeolmos, 28130 Madrid, Spain.
Gutiérrez-Adán
A
A
Brun
A
A
Pintado
B
B
Parra
B
B
Ramírez
M A
MA
Salguero
F J
FJ
Díaz San Segundo
F
F
Rábano
A
A
Cano
M J
MJ
Torres
J M
JM
D017668:Age of Onset; D000818:Animals; D001921:Brain / Q000473:pathology; D002417:Cattle; D004195:Disease Models, Animal; D018450:Disease Progression; D016643:Encephalopathy, Bovine Spongiform / Q000473:pathology*; D020022:Genetic Predisposition to Disease; D006720:Homozygote; D051379:Mice; D008822:Mice, Transgenic; D010641:Phenotype; D018621:PrPC Proteins / Q000032:analysis / Q000096:biosynthesis / Q000235:genetics*; D018620:PrPSc Proteins / Q000096:biosynthesis / Q000235:genetics* / Q000472:pathogenicity; D012091:Repetitive Sequences, Nucleic Acid / Q000235:genetics*; D015996:Survival Rate
D018621:PrPC Proteins; D018620:PrPSc Proteins